SCHEMBL11210952

SCHEMBL11210952

CCSc1ncnc2c1cnn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.66

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ SLC29A1 Q99808 3/20 0.49
▸ ADA P00813 1/20 0.48
▸ ATG7 O95352 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29273711 0.91 SLC29A1 (0.50) SLC29A1ADAATG7
SCHEMBL30935809 0.91 SLC29A1 (0.50) SLC29A1ADAATG7
SCHEMBL30935808 0.89 SLC29A1 (0.52) SLC29A1ADA
SCHEMBL29273715 0.89 SLC29A1 (0.52) SLC29A1ADA
SCHEMBL11213318 0.89 ADA (0.50) SLC29A1ADAATG7
SCHEMBL11210339 0.89 ADA (0.50) SLC29A1ADAATG7
SCHEMBL11210320 0.89 SLC29A1 (0.48) SLC29A1ADA
SCHEMBL9350433 0.87 ATG7 (0.53) SLC29A1ADAATG7
SCHEMBL30935810 0.86 SLC29A1 (0.64) SLC29A1ADAATG7
SCHEMBL30935868 0.86 ADA (0.47) SLC29A1ADAATG7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118355022-A Nucleoside analogues for the treatment of parasitic infections 安特卫普大学 2024-07-16 — — CN disclosed
EP-0021293-B1 4-SUBSTITUTED THIO-1-BETA-D-RIBOFURANOSYLPYRAZOLO(3,4-D) PYRIMIDINES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS AND MEDICAL USES THE WELLCOME FOUNDATION LIMITED (GB) 1983-09-07 — — EP disclosed
EP-0021293-A2 4-Substituted thio-1-beta-D-ribofuranosylpyrazolo(3,4-D) pyrimidines, processes for their preparation, pharmaceutical formulations and medical uses THE WELLCOME FOUNDATION LIMITED (GB) 1981-01-07 — — EP disclosed
US-4201778-A 6-Acyloxy-1,4,6-pregnatrienes, their use as anti-inflammatory agents, methods for their manufacture, and 6-oxo-1,4-pregnadiene intermediates SCHERING CORPORATION (US) 1980-05-06 — — US disclosed
Send feedback